Aditri Neuroscience Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
- Paid Up Capital ₹ 3.05 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 110.04%
- Profit Growth 1524.74%
- Ebitda 105.48%
- Net Worth 9.32%
- Total Assets 6.86%
About Aditri Neuroscience
Aditri Neuroscience Private Limited (ANPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 April 2019 (Five years and ten months 18 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.05 M, as per Ministry of Corporate Affairs (MCA) records.
Kumaar Bagrodia and Rituu Bagrodia serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85310MH2019PTC323794
- Company No.
323794
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Aditri Neuroscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rituu Bagrodia  | Director | 08-Apr-2019 | Current |
| Kumaar Bagrodia | Director | 08-Apr-2019 | Current |
Financial Performance of Aditri Neuroscience.
Aditri Neuroscience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 110.04% increase. The company also saw a substantial improvement in profitability, with a 1524.74% increase in profit. The company's net worth moved up by a moderate rise of 9.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aditri Neuroscience?
In 2022, Aditri Neuroscience had a public holding of 1.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Harivatsa Education Private LimitedKumaar Bagrodia and Rituu Bagrodia are mutual person
Mangalam Exim Private LimitedRituu Bagrodia is a mutual person
- Rastogi Textiles Private Limited
Rituu Bagrodia is a mutual person
- Shree Kumarmangalam Traders Pvt Ltd
Rituu Bagrodia is a mutual person
- Nalini Stockbrokers Private Limited
Rituu Bagrodia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aditri Neuroscience?
Unlock and access historical data on people associated with Aditri Neuroscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aditri Neuroscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aditri Neuroscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
